Makers Of Research-Only Tests Must Respond To Inappropriate Use – FDA Draft Guidance

Diagnostics makers can be held responsible for inappropriate, clinical use of tests labeled for investigational or research use only, if they are aware of it, FDA says in new draft guidance.